Найти в Дзене
Покупайте СтеллыИ дарите их за контент
6 лет назад
 • Вы подписаны

The Medsintez Plant Has Joined the Bioorganika Consortium to Create New Drugs

In June 2020, the Medsintez plant entered an agreement to join the Bioorganika Consortium of the Center for the National Technological Initiative of the Federal State Budgetary Institution ‘Institute of Bioorganic Chemistry named after Academicians M...

6 лет назад
 • Вы подписаны

In Russia Developed a New Feed Additives Production Technology

Biocomposite feed additive for farm animals and poultry, created as part of the REC “Innovative Solutions in the Agro-Industrial Complex”, neutralizes mycotoxins. Thanks to the Belgorod State University scientists’ innovation, the problem of mycotoxins contaminated, poor-quality feed will be solved...

6 лет назад
 • Вы подписаны

Institute of Genetic Technologies to Open in Siberia

A unique centre specializing in innovative “genomic research and genetic technologies” is to open doors at Novosibirsk State University (NSU). The Institute of genetic technologies (IGT), cofounded by...

6 лет назад
 • Вы подписаны

New Technology Can Expand the Potential of Tissue Engineering

Researchers of Tomsk Polytechnic University proposed a method for improving implants for organ regeneration. New technology can expand the potential of tissue engineering. The results were published in the Surface & Coatings Technology. One of the areas of modern biomedicine is the improvement of materials to produce scaffolds. These scaffolds are used as the basis to grow new tissues in regenerative medicine or as a material for targeted drug delivery. The scaffolds with necessary cells or medicines...

6 лет назад
 • Вы подписаны

FDA Approves Pembrolizumab for the Treatment of Patients with Recurrent or Metastatic cSCC

Merck, known as MSD outside the United States and Canada, announced that the U. S. Food and Drug Administration (FDA) has approved Keytruda, merck's anti-PD-1 therapy, as monotherapy for the treatment...

6 лет назад
 • Вы подписаны

Russia Intends to Invest in the Production of Two more Drugs Based on Favipiravir

The Russian Direct Investment fund (RDIF) is considering the possibility of investing in several more Favipiravir-based drugs, chief executive officer Kirill Dmitriev said on June 25. Two more companies...

Покупайте СтеллыИ дарите их за контент